Jennison Associates
CBIO

Jennison Associates’s Crescent Biopharma CBIO Stock Holding History

Jennison Associates’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.81M Buy
+152,974
New +$1.76M ﹤0.01% 427
2019
Q3 		– Sell
-14,167
Closed -$16.9M – 660
2019
Q2 		$16.9M Sell
14,167
-68
-0.5% -$81.3K 0.02% 378
2019
Q1 		$17.7M Buy
14,235
+14
+0.1% +$16K 0.02% 375
2018
Q4 		$13.5M Sell
14,221
-767
-5% -$923K 0.02% 405
2018
Q3 		$21.6M Sell
14,988
-951
-6% -$1.44M 0.02% 388
2018
Q2 		$25.7M Buy
15,939
+263
+2% +$452K 0.03% 363
2018
Q1 		$25.4M Sell
15,676
-202
-1% -$420K 0.03% 358
2017
Q4 		$26.7M Sell
15,878
-24
-0.2% -$31.7K 0.03% 360
2017
Q3 		$22.2M Sell
15,902
-35
-0.2% -$41.1K 0.02% 393
2017
Q2 		$17.8M Buy
+15,937
New +$13.2M 0.02% 425

Other funds holding CBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM